» Articles » PMID: 33379334

Role of Macrophages and RhoA Pathway in Atherosclerosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 31
PMID 33379334
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The development, progression, or stabilization of the atherosclerotic plaque depends on the pro-inflammatory and anti-inflammatory macrophages. The influx of the macrophages and the regulation of macrophage phenotype, inflammatory or anti-inflammatory, are controlled by the small GTPase RhoA and its downstream effectors. Therefore, macrophages and the components of the RhoA pathway are attractive targets for anti-atherosclerotic therapies, which would inhibit macrophage influx and inflammatory phenotype, maintain an anti-inflammatory environment, and promote tissue remodeling and repair. Here, we discuss the recent findings on the role of macrophages and RhoA pathway in the atherosclerotic plaque formation and resolution and the novel therapeutic approaches.

Citing Articles

The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization.

Fedotova E, Berezhnov A, Popov D, Shitikova E, Vinokurov A Int J Mol Sci. 2025; 26(3).

PMID: 39940788 PMC: 11817597. DOI: 10.3390/ijms26031019.


Exploring similarities and differences in anti-atherosclerotic potential bioactives among Dendrobium species by UPLC-Q-Exactive Orbitrap MS.

Zhang Y, Chen X, Tang O, Cheng K, Ge L, Lu W NPJ Sci Food. 2025; 9(1):6.

PMID: 39805828 PMC: 11730587. DOI: 10.1038/s41538-025-00371-5.


Blood Lipoproteins Shape the Phenotype and Lipid Content of Early Atherosclerotic Lesion Macrophages: A Dual-Structured Mathematical Model.

Chambers K, Myerscough M, Watson M, Byrne H Bull Math Biol. 2024; 86(9):112.

PMID: 39093509 PMC: 11297092. DOI: 10.1007/s11538-024-01342-9.


Correlation between Complement C1q A Chain () and Macrophages in the Progression of Carotid Atherosclerosis.

Dong G, Yu X, Zhao M, Lin S, Meng Q Iran J Public Health. 2024; 53(7):1517-1527.

PMID: 39086409 PMC: 11287601. DOI: 10.18502/ijph.v53i7.16046.


Might Gut Microbiota Be a Target for a Personalized Therapeutic Approach in Patients Affected by Atherosclerosis Disease?.

Ciccone M, Lepera M, Guaricci A, Forleo C, Cafiero C, Colella M J Pers Med. 2023; 13(9).

PMID: 37763128 PMC: 10532785. DOI: 10.3390/jpm13091360.


References
1.
Tedgui A, Mallat Z . Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006; 86(2):515-81. DOI: 10.1152/physrev.00024.2005. View

2.
Hanley J . Actin-dependent mechanisms in AMPA receptor trafficking. Front Cell Neurosci. 2014; 8:381. PMC: 4228833. DOI: 10.3389/fncel.2014.00381. View

3.
Merrifield C, Moss S, Ballestrem C, Imhof B, Giese G, Wunderlich I . Endocytic vesicles move at the tips of actin tails in cultured mast cells. Nat Cell Biol. 1999; 1(1):72-4. DOI: 10.1038/9048. View

4.
Hopkins P . Molecular biology of atherosclerosis. Physiol Rev. 2013; 93(3):1317-542. DOI: 10.1152/physrev.00004.2012. View

5.
Uosef A, Vaughn N, Chu X, Elshawwaf M, Abdelshafy A, Elsaid K . Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages. Arch Immunol Ther Exp (Warsz). 2020; 68(3):19. DOI: 10.1007/s00005-020-00584-4. View